Figures & data
Figure 1 Profile of TPX2 expression in prostate cancer and human cancer cells.
Abbreviations: Breast ca., breast cancer; PRAD, prostate adenocarcinoma; Prostate ca., prostate cancer; RT-PCR, reverse transcription-polymerase chain reaction; TCGA, The Cancer Genome Atlas; H, TPX2 high expression; L, TPX2 low expression.
![Figure 1 Profile of TPX2 expression in prostate cancer and human cancer cells.](/cms/asset/be6f1f2b-8cf5-4897-a1b5-4ae13d64ce4b/dott_a_12195537_f0001_c.jpg)
Figure 2 Inhibition of cell growth and reduction of tumorigenesis in human prostate cancer cell lines via TPX2 silencing.
Abbreviation: si-CTL, small interfering negative control.
![Figure 2 Inhibition of cell growth and reduction of tumorigenesis in human prostate cancer cell lines via TPX2 silencing.](/cms/asset/afc98ea6-a609-4e74-aaea-8cd5c9b5d360/dott_a_12195537_f0002_b.jpg)
Figure 3 Increase of sub-G1 and reduction of G1 to S phase cells via TPX2 silencing.
Abbreviations: DAPI, 4′,6-diamidino-2-phenylindole; Noc, nocodazol; si-CTL, small interference-negative control; Thy, thymidine.
![Figure 3 Increase of sub-G1 and reduction of G1 to S phase cells via TPX2 silencing.](/cms/asset/ac33994d-73df-455a-b49a-29c0304ede64/dott_a_12195537_f0003_b.jpg)
Figure 4 PPC1 cell apoptosis caused by TPX2 silencing.
Abbreviations: annexin V(+), annexin V positive; PI, propidium iodide; si-CTL, small interference-negative control; BMP, a image format of windows bitmap.
![Figure 4 PPC1 cell apoptosis caused by TPX2 silencing.](/cms/asset/be2ab34a-24c0-42f3-b50f-410a19ccdb68/dott_a_12195537_f0004_c.jpg)
Figure 5 Depletion of TPX2, as reflected by changes in cell cycle regulation.
Abbreviations: qPCR, quantitative polymerase chain reaction; si-CTL, small interference-negative control.
![Figure 5 Depletion of TPX2, as reflected by changes in cell cycle regulation.](/cms/asset/3009fb36-0248-492d-96c5-db6360e67620/dott_a_12195537_f0005_c.jpg)
Figure 6 Increase in genomic instability via TPX2 depletion, resulting in micronucleation and DNA damage in PPC1 cells.
Abbreviations: CDK, cyclin-dependent kinase; DAPI, 4′,6-diamidino-2-phenylindole; si-CTL, small interference-negative control.
![Figure 6 Increase in genomic instability via TPX2 depletion, resulting in micronucleation and DNA damage in PPC1 cells.](/cms/asset/94201956-5fff-40b2-a8d2-00884b906d41/dott_a_12195537_f0006_c.jpg)
Figure 7 TPX2 depletion changes the cell fitness in LNCap prostate cancer cell line.
Abbreviations: CDK, cyclin-dependent kinase; DAPI, 4′,6-diamidino-2-phenylindole; si-CTL, small interference-negative control.
![Figure 7 TPX2 depletion changes the cell fitness in LNCap prostate cancer cell line.](/cms/asset/127439d9-1689-43a6-aafb-62ea4665cf0b/dott_a_12195537_f0007_c.jpg)